FDA Inspection
CorneaGen, Inc.CorneaGen, Inc. – FDA Inspection, Jun 15, 2016
Record Details
This FDA Inspection record concerns CorneaGen, Inc., with an inspection on June 15, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- CorneaGen, Inc.
- Inspection Date
- June 15, 2016
- Product Type
- Biologics
View Company Profile
ID · 134fd718-00a2-40fe-82d3-32a116632cc5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 977565
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.195(a)Adequate control, proper conditions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CorneaGen, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 10, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 29, 2022 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 27, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 17, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CorneaGen, Inc.
- FDA Inspection 1282090 - 2025-09-10
- FDA Inspection 1176014 - 2022-07-29
- FDA Inspection 1047476 - 2018-02-27
- FDA Inspection 836377 - 2013-06-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.